OBIO’s H2BB™ program connects business talent from graduate level programs across Ontario with health science companies who need interns to help them address key commercialization goals.
The Consulate General of Canada in Boston and MassMEDIC invite emerging Canadian medtech companies to apply to participate in Canadian Mission to MassMEDIC’s MedTech Showcase, on October 26-27, 2017.
Sernova Corp, a leading clinical stage regenerative medicine company, announced that FronTier Merchant Capital Group will provide North American investor relations (IR) and strategic marketing for Sernova with a goal of increasing market awareness through financial market communications.
Six OBIO companies have advanced to the semi-final round of this year's Interface Health Challenge X competition, making it into the Top 50 companies
A new study conducted bythe Canadian Concussion Centre and Dr. Charles Tator has shown that Iris Technologies' Non-LCD E-Paper Technology can decrease the risk of exacerbating symptoms in sufferers of post-concussion syndrome (PCS).
US FDA unveiled its Digital Health Innovation Action Plan last week, including a Software Pre-Certification Pilot Program to facilitate faster market access for digital health products.
Six OBIO companies have advanced to the Top 60 qualifying round for this year's Interface Health Challenge X competition
BIO Investor Forum, an international biotech investor conference focused on early and established private companies, is now accepting applications to present at the October 17-18, 2017 event in San Francisco.
In partnership with Global Affairs Canada, Ontario's Ministry of International Trade is organizing a Health Trade Mission to Japan and Korea, targeting business opportunities in these two important markets.
Intronix Technologies will be launching "Myoguide DOC", a comprehensive software package designed to help clinicians who inject Botulinum Toxins, such as Botox®, Dysport® and Xeomin® to manage their patient's spasticity and pain.